Literature DB >> 29424897

The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation.

X-H Liu1, J Wang, Y-H Dong.   

Abstract

OBJECTIVE: Sp1 is a member of super zinc finger structure family that participates in cancer cells' apoptosis, proliferation, survival, and differentiation. This study detected the expressions of miR-375 and sp1 in colorectal cancer tissue and cells to analyze their impact on cell proliferation. PATIENTS AND METHODS: Colorectal cancer patients in our hospital were enrolled. HCT-116 cell was transfected with miR-375 mimics, mimics control, and miR-375 + sp1, respectively. RT-PCR and Western blot were applied to detect expressions of miR-375 and sp1 at mRNA and protein level in colorectal cancer tissue, para-carcinoma tissue, and normal colorectal tissue. RT-PCR and Western blot were used to test levels of miR-375 and sp1 in HCT-116 cells after transfection. MTT assay was performed to determine HCT-116 cell proliferation.
RESULTS: Our data showed that miR-375 was downregulated, while sp1 was overexpressed in colorectal cancer tissue compared with that in para-carcinoma tissue and normal control (p < 0.05). MiR-375 level was elevated, while sp1 mRNA was declined after miR-375 mimic transfection (p < 0.05). Compared with miR-375 mimic group, the levels of miR-375 and sp1 showed no difference in miR-375 + sp1 group (p > 0.05). Of note, the increase of MiR-375 and reduction of sp1 were in a time-dependent manner (p < 0.05). The cell proliferation rate in miR-375 mimic group was significantly decreased compared with that in mimic control and blank group (p < 0.05). The cell proliferation rate in miR-375 + sp1 group was significantly higher than that miR-375 group, but still lower than the control (p < 0.05). The proliferation rate gradually declined in a time-dependent manner (p < 0.05).
CONCLUSIONS: MiR-375 was decreased and sp1 level was enhanced in colorectal cancer. MiR-375 suppresses the proliferation of colorectal cancer cells via the inhibition of sp1 expression at posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29424897     DOI: 10.26355/eurrev_201801_14188

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  miRNA-708 functions as a tumor suppressor in colorectal cancer by targeting ZEB1 through Akt/mTOR signaling pathway.

Authors:  Sinan Sun; Tianyi Hang; Boyu Zhang; Liang Zhu; Yang Wu; Xiangwei Lv; Qiang Huang; Hanhui Yao
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  High Expression of UPK3A Promotes the Progression of Gastric Cancer Cells by Inactivating p53 Pathway.

Authors:  Deliang Xu; Jing Guo; Hongwei Xu
Journal:  Anal Cell Pathol (Amst)       Date:  2022-06-21       Impact factor: 4.133

3.  Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis.

Authors:  Xiaojun Wang; Hui Ou; Liangfen Zhou; Hengyu Liu; Xiaobao Liu; Huiyun Zhang
Journal:  Exp Ther Med       Date:  2021-05-12       Impact factor: 2.447

4.  SP1-mediated up-regulation of lncRNA TUG1 underlines an oncogenic property in colorectal cancer.

Authors:  Wei Liu; Jin Meng; Rongjun Su; Changjun Shen; Shuai Zhang; Yantao Zhao; Wenqi Liu; Jiang Du; Shuai Zhu; Pan Li; Zhigang Wang; Xiaoxia Li
Journal:  Cell Death Dis       Date:  2022-05-04       Impact factor: 9.685

Review 5.  microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy.

Authors:  Erin W Howard; Xiaohe Yang
Journal:  Biol Proced Online       Date:  2018-09-11       Impact factor: 3.244

6.  ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis.

Authors:  Xuan Li; Zi-Zheng Zou; Min Wen; Yuan-Zhu Xie; Kun-Jian Peng; Tiao Luo; Su-You Liu; Qin Gu; Ji-Jia Li; Zhi-Yong Luo
Journal:  Mol Med       Date:  2020-11-13       Impact factor: 6.354

7.  N-Butanol Fraction of Wenxia Formula Extract Inhibits the Growth and Invasion of Non-Small Cell Lung Cancer by Down-Regulating Sp1-Mediated MMP2 Expression.

Authors:  QianYu Bi; MengRan Wang; Fang Zhao; Meng Wang; XiangJun Yin; JiaZhao Ruan; DeLong Wang; XuMing Ji
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 8.  MicroRNA-375: potential cancer suppressor and therapeutic drug.

Authors:  Jiahui Wei; Yiran Lu; Ruiqing Wang; Xiangzhu Xu; Qing Liu; Song He; Huihao Pan; Xinmiao Liu; Bao Yuan; Yu Ding; Jiabao Zhang
Journal:  Biosci Rep       Date:  2021-09-30       Impact factor: 3.840

9.  Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma.

Authors:  Hao Liang; Mingxing Xu; Zhiyong Xiong; Kunpeng Hu; Jiarui Yang; Mingbo Cao; Zhaozhong Zhong; Zhicheng Yao; Meihai Deng; Bo Liu
Journal:  Aging (Albany NY)       Date:  2021-02-22       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.